Where does ClarVista Medical, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), ClarVista Medical, Inc. ranks #26,012 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does ClarVista Medical, Inc. hold?

ClarVista Medical, Inc. holds 10 US utility patents granted between 2015 and 2018, spanning 1 technology areas.

What is ClarVista Medical, Inc.'s Innovation Score?

ClarVista Medical, Inc. has an Innovation Score of 24.1 out of 100 (14th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is ClarVista Medical, Inc.'s patent grant rate increasing or decreasing?

ClarVista Medical, Inc.'s recent grant velocity is -100% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for ClarVista Medical, Inc.'s patents?

ClarVista Medical, Inc.'s patents average 20.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the ClarVista Medical, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

ClarVista Medical, Inc.

Q: What technology areas does ClarVista Medical, Inc. focus on?

ClarVista Medical, Inc.'s top technology area is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs) with 10 patents, ranking #646 of 3,082 assignees active in that subclass. Grants appear in 1 CPC subclasses total.

USPTO PatentsView assignee record - 10 granted patents across 1 technology areas, recorded in grant years 2015–2018. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Clarvista ranks #26,012 of 49,997 tracked US assignees by granted-patent volume, with 10 patents across 1 technology areas.

#26,012
of 49,997 US assignees by volume: 14th percentile
by Innovation Score (24.1/100): 20.4
avg claims per patent: -100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R26012 · US Corporation #26,012 · 10 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 10 grants
MID-PACK #26,012/49,997
PHOTO-FINISH Chronix Biomedical
CPC-NARROW A61F · 1 areas
INNOV-THIN 24.1/100
CLAIMS-DENSE 20.4 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -100% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Chronix Biomedical (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Clarvista’s 24.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.3 pts (35%) Velocity 0.0 pts (0%) Breadth 3.5 pts (15%) Claim depth 12.2 pts (51%)

Qualcomm Incorporated · highest

85
ClarVista Medical · this assignee

24
3D Lighting… · lowest

7

What this shows Clarvista's Innovation Score is 24.1/100 (14th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Clarvista?

Each dot is one of Clarvista’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Clarvista’s own 20.4 claims/patent is ABOVE the 15.7 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Clarvista vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Clarvista's grants concentrate

ClarVista Medical, Inc. is a focused PatentsView assignee: 1 CPC subclasses with 100% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2018 (4 grants) versus a trough of 1 in 2017. By volume, Clarvista sits between Chronix Biomedical and Clear Labs, Inc.

Chronix Biomedical

10
Cielo Wigle

10
Cipher Trace

10
Clap

10
Clarcor Air Filtr…

10
Claussen Technolo…

10
Clean Hands Safe…

10
Clear Labs

10
Clarvista Medical ◀

10

What this shows ClarVista holds 10 patents at rank #26,042, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near ClarVista

By rank, the assignees closest to #26,042 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in ClarVista's primary technology class.

Clarvista's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

24 14th percentile higher than 14% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2018

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

ClarVista Medical, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	2	20.0%
2016	3	30.0%
2017	1	10.0%
2018	4	40.0%

Which technologies does ClarVista Medical, Inc. patent most?

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 10

Top 1 of 1 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

ClarVista Medical, Inc.'s patent record in context - here's where to go next.

ClarVista Medical, Inc.'s lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 100% of its portfolio - see every assignee active in that class. Explore A61F
Ranked #26,012 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare ClarVista Medical, Inc. against Chronix Biomedical, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 24.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.